Fundraising Fox
Foster City · Seed–Series A · 40 people tracked
Also known as IIF MANAGEMENT COMPANY, LLC
Find your way into Illumina Ventures
Sign up to see every warm intro you have to Illumina Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Illumina Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Illumina Ventures positions itself as a leader in genomics and precision health investing. The firm concentrates on building the broader ecosystem around these fields and translating capital into innovation, with the stated goal of accelerating positive impact on human health.
Source: firm website, verified Sep 29, 2026.
Team · 40 people
from the firm's website & curated & public directories
Founder mafia
The Illumina Ventures mafia →7 people who came through Illumina Ventures went on to found or lead other companies.
What they invest in
from 51 of 58 portfolio companiesBiotech ×46Healthtech ×19AI & Machine Learning ×17Deep Tech ×17Medical Devices ×15Digital Health ×12Hardware ×3AgTech ×2
HQs:United States×38United Kingdom×2France×1Ireland×1Sweden×1
Who they back
founder profiles across 34 portfolio companiesFounding team size:solo founder×122 founders×93 founders×84+ founders×5
Where their founders studiedfrom 37 founders with education data
Case Western Reserve University ×2Harvard Business School ×2Massachusetts Institute of Technology ×2Sharif University of Technology ×2UC San Diego ×2University of Oxford ×2University of Science and Technology of China ×2
What their founders studiedfrom 42 founders with field-of-study data
Life Sciences ×24Engineering ×6Mathematics & Statistics ×5Business & Management ×4Chemistry ×4Computer Science ×3Medicine ×3Physics ×3
Where their founders worked beforefrom 40 founders with career history
Harvard Medical School ×4Massachusetts Institute of Technology ×4Brigham and Women's Hospital ×3UC Berkeley ×310x Genomics ×2Broad Institute of MIT and Harvard ×2Dana-Farber Cancer Institute ×2Harvard University ×2
29 founders hold a PhD · 3 hold an MBA (of 42 with degree data)
Investments · 58 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 22024 · 12023 · 12022 · 42021 · 72020 · 32019 · 22018 · 32017 · 330 dated
Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.
BiotechDigital HealthHealthtechFriendswood, US
Derek J. Maetzold(President, CEO and Director)inFrank Stokes(Chief Financial Officer)inKristen Oelschlager(Chief Operating Officer)inToby Juvenal(Chief Commercial Officer)inHillary Caruso(Chief of Staff)inTobin W. Juvenal(Chief Commercial Officer)
Co-investorsBioBritMountain Group Capital
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.
BiotechHealthtechMedical DevicesAustin, US
Nick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)inCarey-Ann Burnham(Chief Executive Officer)inTravis Davies(SVP, Operations)inKyle Fieleke(SVP, Corporate Development & Finance)inDavid Bussian(SVP, Clinical, Regulatory & Assay Development)in
Co-investorsAMR Action FundIllumina Innovation
Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.
AgTechBiotechClimate TechSt. Louis, US
Barry Goldman(Co-founder)inElizabeth Gallegos(Chief Executive Officer)inJerry Steiner(Executive Chair)inCharlie Walch(Executive Officer, Director)inGlendon Schuster(Director)
Co-investorsFirst In VenturesRadicle GrowthFall Line CapitalGrantham FoundationRA CapitalThe Yield Lab+3 more
Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.
AI & Machine LearningBiotechDigital HealthBoston, US
Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)inSylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)inToni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)
Co-investors5AM VenturesOUP (Osage University Partners)AlexandriaLilly Asia VenturesS28 Capital
Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response.
BiotechDigital HealthMedical DevicesCambridge, US
Irene Ghobrial(Co-founder)inKenneth Anderson(Co-founder)Gad Getz(Co-founder)Romanos Sklavenitis-Pistofidis(Co-founder)Keith Flaherty(Co-founder)Brian McKernan(CEO)in
Co-investorsThe Engine Ventures
RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.
BiotechDeep TechHardwareBoxborough, US
Thomas O'Lenic(Executive Officer, Director)Eugene Ma(Executive Officer)Charles Marshall(Executive Officer, Director)
BoardFrank Smith(Director)inWilliam Cadogan(Director)Bryson Hollimon(Director)
Co-investorsTechnology Venture Partners
Actym Therapeutics engineers bacteria as a delivery system for therapeutics targeting cancer and fibrotic disease.
BiotechHealthtechBerkeley, US
Christopher D Thanos(Executive Officer, Director, Promoter)Kanad Das(Director)Amit Kumar(Director, Promoter)James Huang(Director)
Adventris is a biotechnology company developing cancer immunotherapy treatments.
BiotechHealthtechBaltimore, US
Jen Herbach(Founder)inWilliam Collis(Founder)inMark Yarchoan(Founder)
Co-investorsY CombinatorBlackbird BioventuresFelicis VenturesKhosla VenturesPeak XV PartnersRefactor Capital+1 more
Alamar Biosciences develops NULISA, an ultra-high-sensitivity, high-specificity technology for analyzing hundreds of protein biomarkers from small biofluid samples, building on the team's prior spatial genomics work (RNAscope).
BiotechDeep TechHealthtechFremont, US
Yuling Luo(Co-founder, CEO and Chair)inSteve Chen(Co-founder, COO and Director)inYiyuan Yin(Co-founder, VP of Technology)inTod White(President)inJustin McAnear(CFO)inXiao-Jun Ma(CTO)
Co-investorsQiming Venture PartnersSamsara BioCapital
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
DAVID ARTHUR SCOTT(Executive Officer)inWINSTON XIA YAN(Executive Officer)FENG ZHANG(Director)Feng Zhang, Ph.D.(Arbor Co-founder and Scientific Advisory Board Chair)David Walt, Ph.D.(Arbor Co-founder)David Scott, Ph.D.(Arbor Co-founder)
Co-investorsARCH Venture PartnersOno Venture Investment, Inc.TCG CrossoverAlly Bridge GroupJanus Henderson InvestorsRevelation Partners+4 more
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with 3D genome structural information (via Hi-C sequencing) to detect fusions, rearrangements, ecDNA, and other structural drivers of cancer.
BiotechHealthtechMedical Devices
Sid Selvaraj(Founder & Chief Operating Officer)inTom Willis(Chief Executive Officer)inAnthony Schmitt(Senior Vice President, Science)inErin Davis(Vice President, Marketing)in
Co-investorsBerkeley Catalyst
Attovia is a biotechnology company focused on drug development and clinical strategy, aiming to bring treatments to patients where none exist and create next-generation therapeutic options.
BiotechDigital Health
Zaneta Odrowaz(Founder)inTao Fu, MBA, M.S.(Founder, Chief Executive Officer, and President)Zaneta Odrowaz, Ph.D.(Chief Business Officer and Co-Founder)Petter Veiby(Chief Scientific Officer and Co-Founder)inHangjun Zhan, Ph.D.(Chief Technology Officer and Co-Founder)
Co-investorsEcoR1 CapitalFrazier Life SciencesNextech InvestSanofi VenturesVida VenturesGoldman Sachs+1 more
Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.
AI & Machine LearningBiotechDeep Tech
Co-investorsFirst In VenturesHeran PartnersKorysMérieux Equity Partners
Bullseye Biosciences uses in-cell directed evolution to discover functional therapeutic molecules against challenging intracellular targets such as protein–protein interactions and transcriptional regulation.
BiotechDeep Tech
Corey Gray(Co-founder and CEO)inMichael McKeown(Co-founder and Head of Research)in
Co-investorsZAKA VC
BiotechPittsburgh, US
Michael Hoerres(Executive Officer, Director)
BoardJames Peters(Director)Steve Grenfell(Director)Paul Schmitt(Director)Noel Doheny(Director)
Co-investorsBen Franklin Technology Partners of Northeastern PennsylvaniaPittsburgh Life Sciences Greenhouse
CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.
BiotechDeep TechStockholm, SE
Paulius Mielinis(Founder)inToon Verheyen(Founder)inXiaoyan Qian(Founder)in
Co-investorsLeksell Social VenturesNordic Science InvestmentsVoima Ventures
DeepSeq designs biologic drugs using AI trained on massive datasets of real protein interactions, predicting properties such as affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability.
AI & Machine LearningBiotechDeep Tech
Bernhard Suter(Founder)in
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Victor Velculescu(Founder)inPeter Bach(Executive Officer)Jennifer Buechel(Executive Officer)Douglas Schenkel(Executive Officer)Nicholas Dracopoli(Executive Officer)inSusan Tousi(Chief Executive Officer)in
Co-investorsAV8 VenturesForesite CapitalInitiate Venture PartnersMenlo VenturesMerck Global Health Innovation FundMSD Global Health Innovation Fund+7 more
DNA Script develops enzymatic DNA synthesis technology, producing nucleic acids for research and biotech applications.
BiotechDeep TechHardwareParis, FR
Thomas Ybert(Founder)inXavier Godronin
Co-investorsCatalio Capital Management, LPCoatue ManagementKurma PartnersM VenturesSofinnova PartnersCasdin Capital
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
BiotechSouth San Francisco, US
Stephanie Tagliatela(Founder)inKartik Ramamoorthi, Ph.D.(Co-founder, Chief Executive Officer & Board Member)Kartik Ramamoorthi(Founder)
Co-investorsARCH Venture PartnersBioBritGV (Google Ventures)Menlo VenturesSoftBank Vision FundVenrock+2 more
Develops novel ocular therapies.
BiotechMorrisville, US
Ben Yerxa(Executive Officer)inEric Linsley(Executive Officer)in
BoardEd Mathers(Director)inStephen Bloch(Director)inSeth Rudnick(Director)inNeal Fowler(Director)
Co-investorsCanaan PartnersNew Enterprise Associates (NEA)Pappas Capital+ND CapitalARCH Venture PartnersOMX Ventures
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.
BiotechDeveloper Tools
Co-investorsCivilization Ventures Management, LlcCota CapitalSamsara BioCapital
Fuze Health operates a unified digital healthcare platform spanning digital pharmacy (FuzeRx), clinical services such as diagnostics, screening and genetics (Fuze Services), and data and technology tools (Fuze Technologies).
AI & Machine LearningDigital HealthHealthtechSaaS
Co-investorsFJ LabsHLM Investment PartnersK2 HealthVenturesOlive Tree CapitalQiming Venture Partners USASoftBank Vision Fund+2 more
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtechSouth San Francisco, US
Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in
Co-investorsAlumni VenturesAvestria VenturesCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)+11 more
Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases.
BiotechDigital HealthHealthtechMedical Devices
Co-investorsBlue Ivy VenturesiSelect FundCanaan PartnersWalden Catalyst
Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Hamed Amini(Founder)inSoheil Damangir(Founder)in
Co-investorsAlumni VenturesAME Cloud VenturesFelicis VenturesSeaX Ventures
Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.
AI & Machine LearningBiotechDeep TechSan Diego, US
Tom Miller(Founder)inFred Manby(Founder)inChao Zhang(Executive Officer)inTabbert Teng(Executive Officer)Neil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)in
Co-investorsAscenta CapitalAbingworthCatalio Capital ManagementAlumni VenturesCatalio Capital Management, LPCoatue Management+7 more
Infinity Bio provides immune system analysis through its proprietary MIPSA antibody reactome profiling platform, which identifies the targets of individual immune responses against human viruses, human proteins (autoimmunity), and allergen proteins.
BiotechDeep TechHealthtechBaltimore, US
Benjamin Larman(Executive Officer, Director)inJoy M Nassif(Executive Officer, Director)in
BoardMatthew Hellauer(Director)Herman Scholtz(Director)inCaroline Popper(Director)in
Co-investorsTCP Venture CapitalPTX Capital
Integrated Biosciences is a biotech company developing small molecule therapeutics for age-related diseases, using optogenetics, chemistry, and AI to study aging biology.
AI & Machine LearningBiotechLongevityRedwood City, US
Felix Wong(Executive Officer, Director)inDaniel J. Anderson(Chief Scientific Officer)inThemasap Khan(Director)
BoardKeith Loebner(Director)
Co-investorsSutter Hill VenturesCivilization Ventures Management, LlcOverlap Holdings
Kallyope is a biotechnology company founded by neuroscientists that discovers and develops novel therapeutics targeting neural networks, with a lead candidate in pivotal studies for acute migraine treatment and metabolism programs approaching clinical studies.
BiotechHealthtechNew York City, US
Tom Maniatis(Founder)Nancy Thornberry(Executive Officer, Director)inKenneth Clark(Executive Officer)Charles Zuker(Founder)Richard Axel(Founder)
BoardTerry McGuire(Director)in
Co-investorsDns CapitalLux CapitalThe Column GroupPolaris PartnersTwo Sigma Ventures
Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments.
AI & Machine LearningBiotechMedical DevicesAtlanta, US
Anthony Johnson(Co-Founder & CEO)inDr. Leon Bernal-Mizrachi(Co-Founder, CSO)in
Co-investorsEpidarex CapitalGRA Venture
LetsGetChecked provides at-home healthcare including lab testing, virtual consultations, and prescription fulfillment, backed by its own manufacturing, logistics, and lab analysis infrastructure plus proprietary clinical and analytics software.
Digital HealthHealthtechMedical DevicesDublin, IE
Dr. Robert Mordkin(Chief Medical Officer)Oonagh O'Brien(Chief Executive Officer)inRonan Ryan(Chief Operations Officer)Mike Tesar(Chief Technology Officer)Michael Rummel(Chief Laboratory Officer)inPeter Foley(Founder)
Co-investorsFlucas VenturesK2 HealthVenturesOak HC/FTOptum VenturesTRANSFORMATION CAPITAL
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investors+ND CapitalLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.
BiotechDeep TechMedical DevicesCambridge, GB
Co-investorsARCH Venture PartnersPerscitus LLP+ND CapitalM VenturesOMX Ventures
San Diego, US
Bob Kain(Executive Officer, Director)inDawn Barry(Executive Officer)inJoseph C. Beery(Executive Officer, Director)
Co-investorsARCH Venture PartnersBain Capital VenturesF-Prime Capital
Developer of microfluidic cell sorting technologies for the biotech industry.
BiotechHardwareMedical DevicesSan Diego, US
Jose Morachis(Executive Officer, Director)inNate Heintzman(Executive Officer, Director)inWilliam Alaynick(Executive Officer, Director)Chris Neary(CEO)in
BoardKenneth Hood(Director)
Co-investorsVertical Venture PartnersWarburg PincusAnzu PartnersFusionX VenturesHemisphere Ventures LLCPaladin Capital Group
NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.
AgTechAI & Machine LearningFoodTechDavis, US
Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)
BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in
Co-investorsBetter Ventures Central LlcBlue Horizon CorporationLever VCRhapsody Venture PartnersStray Dog CapitalTrellis Road I Fund AB+1 more
.png)
Oncko develops machine learning and experimental platforms to discover optimized multi-drug cancer treatment combinations by screening against resistance mechanisms.
AI & Machine LearningBiotechDeep Tech
Atray Dixit(Co-founder, CEO)inBill Grossman(Co-founder, Strategic Advisor)in
Co-investorsAdverb VenturesTenmile
Pattern Labs develops autonomous robotics and software systems for airport ground operations and dynamic logistics.
AI & Machine LearningLogistics & Supply ChainRoboticsErie, US
John Pratt(Founder)inMatt Fedick(Founder)in
Co-investorsE12 Venture Capital, LlcOrigin VenturesRPS VenturesService Provider CapitalAxon Partners GroupData Community Fund
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)in
BoardSean Kendall(Director)inMalek Faham(Director)in
Co-investorsARCH Venture PartnersMerck Global Health Innovation FundMSD Global Health Innovation Fund
Santa Clara, US
Jekwan Ryu(Executive Officer, Director)Ronald M. Cook(Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)
BoardTom Willis(Director, Executive Officer)in
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsHatteras Venture PartnersM VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsAbbVie+2 more
BiotechGoleta, US
Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)
Co-investorsIllumina Innovation
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
BiotechHealthtechNew York City, US
Adam Yaari(CEO)inMaxwell Sherman(CTO)in
Co-investorsMetaplanetPioneerSapir Venture PartnersVertex Ventures IsraelY CombinatorAlexandria+5 more
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPCatalio Capital ManagementGood VenturesGV (Google Ventures)Northpond VenturesNovalis LifeSciences
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesLeaps by BayerARCH Venture PartnersFoothill VenturesMedical Excellence CapitalVivo Capital+8 more
BiotechWatertown, US
Robert S. Langer, Sc.D.(Director)Armon Sharei, Ph.D.(Executive Officer, Director)Armon Sharei(Executive Officer, Director)Amy W. Schulman(Executive Officer, Director)Kris Elverum(Executive Officer)Howard Bernstein(Executive Officer)
Co-investorsAlumni Ventures+ND CapitalGV (Google Ventures)InvusJDRF T1D FundQuark Venture Inc.+2 more
Co-investorsKurma PartnersPartech Ventures
Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation.
BiotechDeep TechMedical DevicesChicago, US
Ryan Clarke(Co-Founder, Chief Scientific Officer)inNiko Balanis, PhD(Co-Founder, Chief Technology Officer)inBrad Merrill, PhD(Co-Founder, Head of Innovation)Matt MacDougall, MD, PhD(Scientific Cofounder, Immunology Physician, Stanford University)inPatrick Shaddow(Executive Officer, Director)John Craighead, PhD(Chief Executive Officer)
Co-investorsAstellas Venture Management LLCDCVC (Data Collective)DCVC BioDraper AssociatesPortal InnovationsWalder Ventures
Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB
Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)
Co-investorsCalculus Capital Ltd.IQ CapitalCalculusInnovate UKMEIF Proof-of-Concept & Early Stage FundMercia Ventures+2 more
.jpeg){kind=logo}
BiotechCambridge, US
Shawn Marcell(Executive Officer, Director)Ben Linden(Executive Officer)inDavid Yu Zhang(Director)Peng Yin(Director)
BoardAdam Wiechhaus(Director)
Co-investorsNorthpond Ventures
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Co-investorsARCH Venture PartnersM VenturesNorthpond VenturesNovalis LifeSciences
Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)
Co-investorsFirst Spark Ventures, LlcPandect BioventuresNorthpond Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
DnascriptEncodedgenomicsPredicta
Exits · 1
1 IPOsCastle BiosciencesNASDAQ: CSTL
Portfolio news
latest coverage across their companies
SonoThera · finsmes.com · Jun 10, 2026
Lightcast · finsmes.com · Apr 15, 2026
Vizgen · intelligence360.news · Feb 2, 2026
Frequently asked questions
- How many investments has Illumina Ventures made?
- Illumina Ventures has 58 tracked investments, 1 of which have exited, including 6 dated in the last 24 months.
- What stage does Illumina Ventures invest at?
- Illumina Ventures invests at the Seed, Series A stages.
- What sectors does Illumina Ventures focus on?
- Illumina Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Illumina Ventures located?
- Illumina Ventures is headquartered in Foster City, US.
- Does Illumina Ventures lead rounds?
- Illumina Ventures typically participates in rounds rather than leading them.
- Who does Illumina Ventures co-invest with?
- Illumina Ventures most often shares deals with ARCH Venture Partners, Alumni Ventures, Catalio Capital Management, LP, among 116 tracked co-investors.
- What size deals does Illumina Ventures back?
- Across 14 deals with disclosed amounts, Illumina Ventures has joined rounds of $2.5M – $215M (median $23.5M).
Co-investors · 11
+ND Capital is a venture capital firm founded in 2002 focused on nanotechnology and deep science investments, backing companies in life sciences and physical sciences primarily in the US and Europe.
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Catalio is a software platform that uses AI to automatically extract and document business logic from legacy and modern systems, creating living specifications that stay current as software evolves.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Transformation Capital is an investment firm focused exclusively on the digital healthcare industry, backing founders working to transform and modernize health.
Paladin Capital Group invests in early stage and growth companies developing cyber, AI and deep technologies that address security and resilience needs for commercial and government customers.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
Qiming Venture Partners (启明创投) is a China-focused venture capital firm that invests in and supports early- and growth-stage technology and healthcare companies, providing capital, industry resources, and strategic guidance through milestones such as financing, IPOs, and M&A.
EQT Life Sciences (formerly LSP) is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally.
Genoa Ventures is a venture capital firm that works with strategic partners providing market insights, validated deal flow, and domain expertise to support its portfolio companies.
Firms observed investing alongside Illumina Ventures, from public investor directories. Shared companies are the overlap with Illumina Ventures's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.